Aethlon Medical Inc.
AEMD | NASDAQ
$6.32
+$0.01 (+0.16%)
At close: Sep 21, 2026, 4:00 PM ET
$6.21
-$0.11 (-1.74%)
Pre-market:
Sep 22, 2026, 6:57 AM ET
+0.16%
(1D)Rating
Updated: Aug 24, 2026Key Statistics
Market Data
Market Cap $3.33M
1D Range
6.11 6.39
52W Range
1.41 41.50
Valuation (TTM)
PE -0.54
PB 0.64
EV/EBITDA 0.19
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $1.50
Cash Flow
FCF Yield -57407.0%
SBC Adj. FCF Yield -58915.2%
SBC Impact -2.6%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
-61.0%
Dil EPS 3Y | 5Y 114.5% |
53.5%
FCF 3Y | 5Y -147.9% |
-97.3%
Returns
ROA -111.3%
ROE -123.1%
ROIC -127.2%
Financial Health
Net Cash
$4.82M
Current Ratio 5.42
Interest Coverage -492.66
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the Unit...
Sector Healthcare
Industry Medical - Devices
Employees 9
IPO Date Mar 3, 1999
Website www.aethlonmedical.com
Fiscal Year April - March
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove AEMD